MNKD MannKind Corporation
$3.63▲ +1.68%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$1.12B
P/E Ratio
–
Div Yield
–%
52W Range
2.23 - 6.51
% vs 50 MA
18.12%
% vs 200 MA
-21.65%
RSI-14
58.9
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.14
Free Cash Flow
-$7.25M
Gross Rev
$90.17M
Gross Profit
$72.70M
EBITDA
$2.53M
COGS
$17.47M
Operating Exp
$75.68M
Operating Income
-$2.99M
EBIT
-$2.99M
Pretax Income
-$16.37M
Net Income
-$16.62M
EPS (Diluted)
-0.05
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Mar 2026 (Quarterly)
Social Sentiment
Avg +0.25 · 4 posts
DDDiscussionHere’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10
r/wallstreetbets · Jan 31, 2025
The comments express significant skepticism and negative historical performance, indicating a bearish sentiment.
negative
+0.10
Discussion$UTHR and $MNKD
r/wallstreetbets · Sep 16, 2024
The author discusses the potential for the company with relation to future developments.
positive
+0.70
NewsEarningsDDPriceTargetAll You Need To Know About MannKind Corporation (MNKD) Before You Buy
r/wallstreetbets · Sep 9, 2024
The post highlights revenue growth, analyst forecasts, a Zacks Rank upgrade, and the innovative Afrezza product, indicating a bullish outlook.
positive
+0.80
DDDiscussionLong in Mannkind Corporation
r/wallstreetbets · Jun 4, 2024
The post expresses concern about the product's market performance and describes Mannkind as 'just another company', indicating a bearish outlook.
negative
-0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.